510(k) K033908
K033908 is an FDA 510(k) premarket notification submitted by Dade Behring, Inc. for the device "N HIGH SENSITIVITY CRP". The FDA issued a decision of Substantially Equivalent on Jan 22, 2004. The device falls under product code NQD (Cardiac C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Dade Behring, Inc. has 342 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 22, 2004
- Date Received
- Dec 17, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type
- 510(k)
In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.
Need the full FDA record for Dade Behring, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.